Led financial strategy, operations, and business partnering activities across EMEA, APAC, and LATAM with sales of up to $14 billion. Oversaw financial planning and analysis, controlling, accounting, reporting, tax, compliance, and risk management, ensuring adherence to international and local standards. As a member of the international executive leadership, provided strategic financial guidance on business strategy, growth initiatives, market entry, product launches, pricing strategies, and expansion plans. Ensured that resources were fully aligned with both strategic and operational priorities, while managing costs to drive profitable growth.Key achievements:• GLOBAL EXPANSION: Spearheaded Moderna’s international expansion from the ground up as part of the regional executive leadership, collaborating to define expansion strategy, go-to-market models, market access, and pricing strategies. Established over 15 new commercial entities, along with several commercial alliances and manufacturing partnerships across the region.• TEAM DEVELOPMENT & LEADERSHIP: Recruited, led, and developed a high-performing international finance team of 70 highly skilled professionals spread over different countries and continents.• SHARED SERVICES: Established and led a cross-functional center of excellence (COE) in Poland hosting over 200 associates across finance, HR, digital, legal, pharmacovigilance, regulatory affairs, supply chain, and project management.

Managed the global external supply P&L and balance sheet (Inventory/CAPEX) with over $2 billion in spend across 10,000 SKUs and several hundred manufacturing sites worldwide. Led financial strategy, resource allocation, and investment decisions across multiple technical platforms. Directed financial planning and performance management, actively collaborating with global leadership to drive operational efficiency and manage risks and opportunities.Key achievements: • COST SAVINGS: Collaborated with the team to identify and achieve over $100 million in annual savings from $2 billion spend..• ORGANIZATIONAL TRANSFORMATION: Played a key role in the external supply team restructuring, offshoring, and merging with internal manufacturing organizations.• FINANCIAL GOVERNANCE: Implemented robust financial transparency and governance frameworks, ensuring accountability for savings across external supply teams.

Led corporate actions, including a spin-off, M&A financing, and bond issuances. Prepared recommendations for the Board on capital structure, credit ratings, and dividend policies. Managed credit rating agency relationships, negotiated conditions with banks, and responded to investor queries. Directed liquidity forecasting, debt capacity analysis, and share repurchase program oversight.Key achievements: • SPIN-OFF AND IPO: Led capital market aspects for Alcon’s NYSE and Swiss Exchange listing, the largest EU spin-off.• M&A FINANCING: Structured and executed the $8.7 billion AveXis acquisition financing.• CAPITAL MARKETS FINANCING: Planned and executed €2 billion in bond issuances, achieving cost-efficient results.

Managed the group's financial planning process, including strategic plan, budgets, and forecasts. Oversaw the group's free cash flow and forecasting of FX impacts on financials. Served as Group FP&A lead for 2 divisions (sales $4 billion). Supported the group CFO in setting and monitoring objectives, defining corrective actions and preparing investor and Board presentations.Key achievements:• CASH FLOW OPTIMIZATION: Led a cross-divisional improvement project in collaboration with division CFOs, identifying significant upside, versus budget ($0.5 billion) and versus the strategic plan ($2 billion)• MANUFACTURING FOOTPRINT: Financially guided a group-wide initiative, resulting in the reduction of 25 production sites and associated cost savings.

Led the post-merger integration of Alcon’s Financial Reporting and Accounting across 30 European units with $2.3 billion in sales. Designed and implemented a new organizational structure, executed legal entity mergers across Europe, and led the implementation of Novartis practices in close collaboration with Alcon’s regional and country management.Key achievements: • INTEGRATION & CHANGE MANAGEMENT: Successfully implemented the Novartis Financial Controls framework across 30 commercial and manufacturing entities, driving significant cultural change.• INTERIM LEADERSHIP: Stepped in as interim Head of Alcon’s Europe Transactional Shared Service during an emergency, leading 80 accountants through year-end close.

Led operational accounting and reporting under IFRS and HGB, ensuring SOX compliance for two divisions ($230M sales). Transformed the team into a service-oriented partner, optimized processes, implemented SAP systems, and oversaw accounting and reporting functions across three divisions in Central Europe.

Oversaw all financial, IT, and operational aspects, including customer service, supply chain, and relationships with shared services (Legal, Tax, HR). Led a strategic business turnaround, redefining the strategy and go-to-market model, significantly improving performance—recognized and awarded by the Global Divisional Executive Committee.